BBSI calls the bottom on California workers' comp — the payoff lands in 2027

Barrett Business Services spent years warning that California's workers' compensation pricing was at a breaking point — and in Q2 2026 the confirmation finally arrived. The company recorded its eighth consecutive month of higher workers' comp rate increases, the first sustained multi-month stretch of pricing upticks in more than a decade. The CEO's tone has shifted from cautious hedging to an outright declaration, now backed by real data: “we now believe that turning point has arrived with insurers pushing rate for the first time in more than a decade” — Gary Kramer, President and Chief Executive Officer · 2026-08-05 — reinforced by the California Insurance Commissioner approving back-to-back average increases (8.7% in 2025, 6.6% effective September 2026) as industry claim costs, led by a 2.5x surge in litigated cumulative-trauma claims, finally outran falling prices.

We're pretty comfortable that we can call the bottom now and say that we are seeing this rate environment lift up.

The turn matters because of what it reverses and how long it took. Back in February, Kramer described the same market as “choppy and inconsistent” — Gary Kramer, President and CEO · 2026-02-26 — good months and bad months with no sustained trend. A year earlier (May 2025) he would only concede he was “closer to the bottom now than we've ever been.” — Gary Kramer, President and CEO · 2025-05-07 The shift from “closer” to “called” is the kind of conviction change that separates this quarter from six straight quarters of “the inflection is coming.” It is also squarely a company-specific signal: it appears nowhere in the market's current keyword currents of tariffs, IEEPA refunds, or AI-grid buildout that dominate the broader rate environment conversation elsewhere.

The low-watermark math

Why does the payoff land in 2027 and not 2026? Mechanism. Clients renew monthly, so each month's higher price rolls in gradually rather than all at once. Management has framed 2026 as a deliberate trough — narrowing full-year gross margin guidance to 2.7%–2.75% of gross billings (from a prior 2.7%–2.85%), trimming the gross-billings outlook to +3%–4%, and cutting average WSE growth to +2%–3% — while promising that 2027 picks up the compounding:

The fundamentals back the framing. On a revenue basis, gross margin peaked around 23% back in 2019Q3 and has spent years drifting down. The favorable prior-year reserve adjustments that cushioned recent results shrank to $2M in Q2 2026 from $8.8M a year earlier, as actuarial estimates absorbed the higher claim-cost expectations into current-year numbers.

The genuine tension is the volume side. New client acquisitions rose 17% year-over-year, retention stayed high, and asset-light markets grew 73% — the strong controllable growth engine investors have come to expect. But the client workforce reductions that began in Q3 2025, moderated in Q1 2026, and then resumed in Q2 held total worksite employees to just +1% growth and gross billings to +2.6% (below plan). Kramer's own words capture the offset: “macro and geopolitical headwinds continue to constrain our existing clients' ability to grow their own workforces.” — Gary Kramer, President and Chief Executive Officer · 2026-08-05 Staffing (-18%) showed the same shape: new business outpaced runoff, but existing clients kept orders on hold amid the cost trends uncertainty.

The market's two-sided read

The tape tells the same story. The stock is still roughly a third off its September 2025 peak of $49.17 — the drawdown that began precisely as the client workforce cuts started. Yet the last 90 trading days show a +18.6% run that crested at $41.05 on July 28 before giving back ~18%, as the narrowed guidance and “margin from here” patience met the late-July enthusiasm head-on. Management is buying through it: $15M repurchased in Q2 at a $30.92 average, with $40M remaining under the $100M program, on a balance sheet with $68M of unrestricted cash and investments and zero debt. Valuation has de-rated to roughly 10.8x price to operating income — down a third year-over-year, consistent with a market pricing the trough rather than the recovery.

For a $762M PEO whose fortunes are set by an obscure state pricing cycle while the rest of the tape chases AI and tariff headlines, the setup is unusually clean: a multi-year, repeatedly promised cyclical inflection with confirmation finally in hand. If 2027 margins inflect as modeled, today's multiple may look cheap in hindsight; if the rate cycle rolls over again, the 2019–2025 grind resumes. The market is now being asked to pick which future to price — and that is why this otherwise modest print matters more than its +2.6% billing growth would suggest.